Publication | Open Access
The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate
94
Citations
12
References
1992
Year
BacteriologyGlycobiologyCytoplasmic Peptidoglycan PrecursorAntimicrobial ChemotherapyDrug ResistanceMedical MicrobiologyAntimicrobial ResistanceHealth SciencesBiochemistryAntimicrobial CompoundClinical MicrobiologyAntimicrobial SusceptibilityAntibioticsVancomycin Resistance PlasmidsPeptoidMass SpectrometryMicrobiologyMedicineVancomycin Binding
Vancomycin resistance plasmids in enterococci carry the genes vanH and vanA, which encode enzymes catalyzing, respectively, the reduction of 2-keto acids to 2-D-hydroxy acids and the addition of D-hydroxy acids to D-alanine. It has therefore been postulated that resistant cells produce peptidoglycan precursors that terminate in the depsipeptide D-alanine-2-D-hydroxy acid rather than the dipeptide D-alanine-D-alanine, thus preventing vancomycin binding (M. Arthur, C. Molinas, T. D. H. Bugg, G. D. Wright, C. T. Walsh, and P. Courvalin, Antimicrob. Agents Chemother. 36:867-869, 1992). In the present work, a cytoplasmic peptidoglycan precursor was isolated from vancomycin-resistant Enterococcus faecalis and analyzed by mass spectrometry, which suggested the structure UDP-N-acetyl-muramyl-L-Ala-D-Glu-L-Lys-D-Ala-D-lactate.
| Year | Citations | |
|---|---|---|
Page 1
Page 1